PATIENTS taking blockbuster diabetes and weight loss drugs are waking up with vision loss, researchers warn. Some reported ...

A small study confirms observations what users have observed: the medications reduce their cravings for alcohol.

Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and ...

Injections like Wegovy have been hailed 'wonder-drugs' for their ability to help with a number of health conditions ...

In fact, Novo Nordisk recently reported positive results for one of its anti-obesity candidates that puts its current best-selling drug in this area, Wegovy ... loss of 22% after 36 weeks.

Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.

Friday’s announcement came two weeks before the ... for Ozempic and Wegovy, in particular, would open a new front in the debate over the cost of some of the most sought-after medications in ...

The Biden administration announced the list well before a February ... as 20 can be chosen each time after that. The administration treated Ozempic, Rybelsus and Wegovy — different formulations ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 ... Services Secretary Xavier Becerra told reporters. “It lets us go after the biggest cost drivers in the prescription drug field for ...

LONDON/COPENHAGEN (Reuters) -Obesity drug maker Novo Nordisk (NVO) forecast slower growth this year after Wegovy sales more ... Novo's stock rose 3% before the bell on Wednesday.